Crinetics Pharmaceuticals, Inc. (CRNX)
55.99
-0.44
(-0.78%)
USD |
NASDAQ |
Jan 16, 16:00
57.00
+1.01
(+1.80%)
After-Hours: 20:00
Crinetics Pharmaceuticals Shareholders Equity (Annual): 1.325B for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 754.38M |
| GT Biopharma, Inc. | -1.67M |
| Axsome Therapeutics, Inc. | 57.02M |
| Sutro Biopharma, Inc. | 44.60M |
| Gossamer Bio, Inc. | 29.49M |